RecruitingNCT06718569

Pain in Inflammatory Joint Diseases

Advancing the Understanding of Pain Mechanisms in Inflammatory Arthritis Towards Precision Pain Management


Sponsor

Diakonhjemmet Hospital

Enrollment

350 participants

Start Date

Nov 11, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Our primary objective is to better understand the etiology and consequences of chronic paint by using an explorative approach to identify phenotypes and endotypes of patients with inflammatory joint diseases, with a special focus on central sensitization and cognitive functioning as a key element in chronic pain. We will also examine the risk factors and clinical impact of these factors on pain, disease activity and treatment effects in a longitudinal study of patients with inflammatory joint disesases.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • All patients who initiate or switch biological or targeted synthetic DMARDs

Exclusion Criteria1

  • None

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGBiological or targeted synthetic DMARD

All biological or targeted synthetic DMARDs that are available for treatment of patients with inflammatory joint diseases


Locations(1)

Diakonhjemmet Hospital

Oslo, Norway

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06718569


Related Trials